Dysregulation of the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) axis has been heavily implicated in tumorigenesis and the progression of numerous cancers, including lung, thyroid, ovarian and gastric cancer [2,3,4,5]. The gene discussed is MTOR; the disease is cancer.